The Efficacy and Plasma Ctdna As a Biomarker of Dual PD-1 and HER2 Blockade in HER2-Positive Gastric or Gastroesophageal Junction Cancers
SSRN Electronic Journal（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined